Riskpilot← Back to searchSign inGet full accessMINDMED AS
ASActiveOrg 919437901Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20170 employees
Revenue 2022
NOK 49K
-94% vs 2021
EBITDA margin
50.0%
-93% vs 2021
Equity ratio
97.5%
Financial strength
Net profit 2022
NOK 27K
-90% vs 2021
| Revenue | NOK 49K | -94% |
| EBITDA | NOK 24K | -93% |
| Net profit | NOK 27K | -90% |
| Total assets | NOK 636K | -19% |
| Equity | NOK 620K | +5% |
| Employees | 0 | — |
Legal name
MINDMED AS
Org number
919437901
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. august 2017
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Engroshandel med sykepleie- og apotekvarer.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 2 192 | 710 | 803 | 49 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 62 | 60 | 365 | 24 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 62 | 60 | 365 | 24 |
| Net financials | 0 | 0 | 34 | 1 | −18 | 10 |
| Profit before tax | 0 | 0 | 96 | 61 | 347 | 34 |
| Tax | −0 | 0 | 21 | 13 | 76 | 8 |
| Net profit | 0 | 0 | 75 | 48 | 271 | 27 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Total assets | 206 | 200 | 2 130 | 1 038 | 782 | 636 |
| Equity | 200 | 200 | 275 | 323 | 594 | 620 |
| Long-term debt | 0 | 0 | 1 532 | 432 | 0 | 0 |
| Short-term debt | 6 | 0 | 323 | 284 | 188 | 16 |
| Total debt | 6 | 0 | 1 855 | 715 | 188 | 16 |
EBITDA margin
50.0%
This company
15.8%
Market median
+216% vs market
20172022
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20172022
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20172022
Net profit margin
55.2%
This company
8.1%
Market median
+581% vs market
20172022
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20172022
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20172022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-06-07 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BV Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Dico As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fundingsrud Holding As
MINDMED AS Board members of MINDMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bård Vegard Marken | Chief Executive Officer | 0 companies |
| Lasse Fundingsrud Bydal | Board of Directors | 0 companies |
| Jan Knoph | Chairman | 0 companies |
| Jens Ole Ørneberg | Board of Directors | 0 companies |